MedTrace Logo

Peri-implant Marginal Bone Loss and Implant Failure in Patients With Smoking Habit

NCT05390242 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2022-05-25

No results posted yet for this study

Summary

The impact of smoking on dental implant failure has been a constant topic of discussion for the past decade and the current literature confronts the inconclusive evidence of tobacco for a marginal bone loss risk factor. The aim of the present investigation is to determine the association between tobacco and marginal bone loss or implant failure in a sample of patients who had received implant-supported restorative therapy in the Dentistry Hospital of the University of Barcelona (Campus of Bellvitge).

Considering that peri-implant marginal bone is essential for dental implant success, in this study we would like to establish the relationship between marginal bone loss around implants and smoking, in our own population study, in order to improve the prognosis of implant success in smoking patients.

On the other hand, knowing the negative effect tobacco has on marginal bone loss in dental implants, we will be able to better predict peri-implant bone loss and reveal the probability of implant failure in short and long-term in smokers. By informing the patient correctly, we can raise awareness and create an additional reason for them to stop smoking, or at least reduce the number of cigarettes they smoke per day.

Conditions

  • Dental Implant Failed
  • Marginal Bone Loss
  • Smoking

Interventions

DIAGNOSTIC_TEST

Radiographic study

Candidates undergo a radiographic study (Orthopantomography and Implant periapical radiography)

Sponsors & Collaborators

  • University of Barcelona

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-21
Primary Completion
2022-05-25
Completion
2022-06-05

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05390242 on ClinicalTrials.gov